Cutaneous phototoxic occurrences in patients receiving Photofrin.
about
Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell lineInfluence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cellsKinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus.Comparison of 5-aminolaevulinic acid and porphyrin photosensitization for photodynamic therapy of malignant bronchial stenosis: a clinical pilot study.Effects of visible light on the skin.Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice.Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.Novel photodynamic therapy against biliary tract carcinoma using mono-L: -aspartyl chlorine e6: basic evaluation for its feasibility and efficacy.Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.Tissue uptake study and photodynamic therapy of melanoma-bearing mice with a nontoxic, effective chlorin.Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival.Tissue damage in the canine normal esophagus by photoactivation with talaporfin sodium (laserphyrin): a preclinical studyPhotosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot studyCutaneous penetration of the topically applied photosensitizer Pc 4 as detected by intravital 2-photon laser scanning microscopy.Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.Photodynamic therapy of human lung cancer xenografts in mice.Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acidPhotodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiationsCorrelation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinomaMechanisms for optimising photodynamic therapy: second-generation photosensitisers in combination with mitomycin C.Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinomaEnhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study.Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.Photodynamic therapy for the treatment of atherosclerotic plaque: Lost in translation?Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC)Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugsPhotodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot studyEffect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neckEffects of photodynamic therapy on leucocyte-endothelium interaction: differences between normal and tumour tissueMethyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.Photodynamic therapy for gynecological diseases and breast cancerPhotosensitization of the rat endometrium following 5-aminolevulinic acid induced photodynamic therapy.Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.Photodynamic Activity of Liposomal Photosensitizers via Energy Transfer from Antenna Molecules to [60]FullerenePhotodynamic activity of BAM-SiPc, an unsymmetrical bisamino silicon(IV) phthalocyanine, in tumour-bearing nude mice.Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications.A comparison of direct and liposomal antibody conjugates of sulfonated aluminum phthalocyanines for selective photoimmunotherapy of human bladder carcinoma.
P2860
Q28379069-30C1BD65-FE60-4392-B6AB-B15E320823B8Q28379164-27BD6F98-5F41-4382-BF05-85F4E304BDECQ30642020-A69BE542-3BB5-4C10-B2D4-2AF0EACFC4C7Q30816638-47C5391C-EA98-4E10-961F-73C14D5195F6Q30840740-8B9EA9F7-4447-42C0-9F9C-42C2DA5F6643Q30883272-610EB8AB-BF0F-4938-A54A-DB37DE39CCA0Q31032596-162FBD7B-FFCD-47A3-A6A9-0CC36F6A29D7Q33280687-4E78204A-56F3-4658-A9F8-07DC46D98859Q33577075-4B0ACA8D-7A05-4AE0-A2C6-17E7B47CCD6BQ33915542-ECB6D0AC-30D0-4AC7-8715-A4F162652CE3Q33952783-7BD9EF8D-1F91-4394-9518-BB7929993160Q34158992-DD9FEE24-18E1-4922-9F2A-60981C5454BCQ34311858-30B999FF-C0E9-4579-BEE0-28DF613DB504Q34407455-73B62E99-CDEF-4473-AA7B-C9BA7357207DQ34409083-41DB5B68-B8C8-485D-A2B6-40AC9A439B34Q34609484-C55E7043-C595-4D9C-AF37-50DE35E54008Q35818104-72F66604-CB0E-4146-956D-75803E81958FQ36079432-2595F6D3-496F-4CB6-9F8C-E16A01D39C82Q36080027-A875870F-5C1F-4811-94B1-F20DD1A1CC18Q36080285-1A87B948-954C-4427-88A5-AA686018BB18Q36081132-8D83C8B4-BE7B-4E1D-BEA2-4ED54C409F12Q36081554-20FB645B-A18E-4711-B8C9-3E85397A8740Q36115598-D19F14F5-929D-406B-8589-B14222AE4677Q36138687-99699B23-EE27-4663-9D5F-B6A36B63EEDFQ36145722-B2CF3BB5-DFC3-4B1B-8828-087E39634239Q36205310-19C46A50-5D93-4EFA-8E80-F77F482CFF8BQ36431077-9DF9FA51-5BBB-4205-B476-45E3DFC51FEAQ36502354-F349F238-27AD-438D-AA35-7817ED910576Q36620119-F626D89E-115F-403E-AC13-1024525380ECQ36621862-72899CAC-06D8-4266-9FD2-1A6B5FA53181Q36683617-E8F40E11-6949-45C9-A86C-93D0FEE05FAEQ36785868-20C4D085-CF7A-40F5-9CF0-633405AE6F79Q36814295-0D28F961-3C58-488F-BB5D-61B49CD20A07Q36816143-5E99C39C-1778-49BA-BC9E-6757BBC3FF41Q36822754-E3FAA9DD-03BA-4A14-AB01-34A93A1F5715Q39157590-A308B968-F7E6-4F45-BDF0-4151F7CE2546Q39542782-06731403-F2AD-4B93-BB3C-224BEF999B14Q39571260-4F69E787-DD68-4586-B684-17EDDABD2FD3Q41110143-91BC3924-B91C-4551-BFD5-426DA1263CC3Q41433562-1D99F8AF-C6D4-448B-B9C1-6B4EBB49A390
P2860
Cutaneous phototoxic occurrences in patients receiving Photofrin.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@ast
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@en
type
label
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@ast
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@en
prefLabel
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@ast
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@en
P2093
P356
P1476
Cutaneous phototoxic occurrences in patients receiving Photofrin.
@en
P2093
P304
P356
10.1002/LSM.1900100514
P577
1990-01-01T00:00:00Z